41 Preliminary results of a randomized comparative phase III trial of topotecan (T) versus CAV as second-line therapy of small cell lung cancer (SCLC)

Lung Cancer ◽  
1997 ◽  
Vol 18 ◽  
pp. 13-14 ◽  
Author(s):  
J.H. Schiller ◽  
J. von Pawel ◽  
P. Clarke ◽  
J.P. Kleisbauer ◽  
T. Dobbs ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Iii ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Phase Iii Trial ◽  
Line Therapy

Second-line therapy of squamous non-small cell lung cancer: an evolving landscape

2017 ◽  
Vol 11 (6) ◽  
pp. 469-479 ◽  
Author(s):  
Chiara Lazzari ◽  
Niki Karachaliou ◽  
Vanesa Gregorc ◽  
Alessandra Bulotta ◽  
Maria Gonzalez-Cao ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

Second-Line Therapy for Non–Small-Cell Lung Cancer

2009 ◽  
Vol 10 (2) ◽  
pp. 91-98 ◽  
Author(s):  
Belisario A. Arango ◽  
Aurelio B. Castrellon ◽  
Edgardo S. Santos ◽  
Luis E. Raez
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document